Hemophilic arthropathy.
D000135:Acid Phosphatase / Q000032:analysis; D000208:Acute Disease; D000328:Adult; D000700:Analgesics / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001779:Blood Coagulation Factors / Q000627:therapeutic use; D002403:Cathepsins / Q000032:analysis; D002908:Chronic Disease; D003450:Cryoglobulins / Q000627:therapeutic use; D005164:Factor IX / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D005612:Freeze Drying; D006395:Hemarthrosis / Q000209:etiology; D006467:Hemophilia A / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy; D006701:Home Nursing; D006801:Humans; D007592:Joint Diseases / Q000000981:diagnostic imaging / Q000473:pathology / Q000628:therapy; D008297:Male; D009132:Muscles; D011859:Radiography; D013582:Synovial Fluid / Q000201:enzymology; D013583:Synovial Membrane / Q000201:enzymology
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D001779:Blood Coagulation Factors; D003450:Cryoglobulins; D005169:Factor VIII; D005164:Factor IX; D000135:Acid Phosphatase; D002403:Cathepsins